Onset and resolution of ovarian toxicity with nirogacestat treatment in females with desmoid tumors: Updated safety analyses from the DeFi phase 3 study
Cancer. 2024 May 4. doi: 10.1002/cncr.35324. Online ahead of print. ABSTRACT INTRODUCTION: Nirogacestat is a targeted gamma secretase inhibitor approved in the United States for …